D
80.04
4.22 (5.57%)
| Penutupan Terdahulu | 75.82 |
| Buka | 75.47 |
| Jumlah Dagangan | 11,450,882 |
| Purata Dagangan (3B) | 4,196,973 |
| Modal Pasaran | 31,263,223,808 |
| Harga / Pendapatan (P/E TTM) | 48.51 |
| Harga / Pendapatan (P/E Ke hadapan) | 38.02 |
| Harga / Jualan (P/S) | 8.19 |
| Harga / Buku (P/B) | 15.39 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Feb 2025 - 10 Feb 2025 |
| Margin Keuntungan | 17.22% |
| Margin Operasi (TTM) | 15.29% |
| EPS Cair (TTM) | 1.65 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 2.00% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 11.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 130.94% |
| Nisbah Semasa (MRQ) | 2.46 |
| Aliran Tunai Operasi (OCF TTM) | 821.70 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 353.22 M |
| Pulangan Atas Aset (ROA TTM) | 6.06% |
| Pulangan Atas Ekuiti (ROE TTM) | 32.06% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | DexCom, Inc. | Menurun | Menurun |
AISkor Stockmoo
1.3
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | -1.0 |
| Osilator Teknikal | 2.0 |
| Purata | 1.25 |
|
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Mid Growth |
| % Dimiliki oleh Orang Dalam | 0.31% |
| % Dimiliki oleh Institusi | 97.10% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 115.00 (RBC Capital, 43.68%) | Beli |
| Median | 94.00 (17.44%) | |
| Rendah | 85.00 (JP Morgan, 6.20%) | Pegang |
| Purata | 95.67 (19.53%) | |
| Jumlah | 8 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 75.55 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Citigroup | 11 Dec 2024 | 91.00 (13.69%) | Beli | 80.47 |
| Wells Fargo | 11 Dec 2024 | 94.00 (17.44%) | Beli | 80.47 |
| 25 Oct 2024 | 90.00 (12.44%) | Beli | 73.44 | |
| Canaccord Genuity | 09 Dec 2024 | 99.00 (23.69%) | Beli | 78.41 |
| Bernstein | 25 Oct 2024 | 86.00 (7.45%) | Beli | 73.44 |
| JP Morgan | 25 Oct 2024 | 85.00 (6.20%) | Pegang | 73.44 |
| Leerink Partners | 25 Oct 2024 | 87.00 (8.70%) | Beli | 73.44 |
| Oppenheimer | 25 Oct 2024 | 105.00 (31.18%) | Beli | 73.44 |
| RBC Capital | 25 Oct 2024 | 115.00 (43.68%) | Beli | 73.44 |
| 08 Oct 2024 | 120.00 (49.93%) | Beli | 69.43 | |
| Raymond James | 25 Oct 2024 | 99.00 (23.69%) | Beli | 73.44 |
| Papar semua | ||||
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 17 Dec 2024 | Pengumuman | Dexcom Launches the First Generative AI Platform in Glucose Biosensing |
| 17 Dec 2024 | Pengumuman | Alberta Government Lifts Age Restrictions on Continuous Glucose Monitors (CGM) and Eligible Albertans With Type 1 or Type 2 Diabetes Can Now Access Dexcom G7 CGM |
| 19 Nov 2024 | Pengumuman | Dexcom and ŌURA Announce Strategic Partnership |
| 14 Nov 2024 | Pengumuman | Dexcom Helps People With Diabetes Take the First Step to Discover What They’re Made Of on World Diabetes Day |
| 29 Oct 2024 | Pengumuman | Glucoguard, a Division of ADHC, Completes AI Based Mobile Application and Design Outline (MADO) for Dexcom API Integration |
| 24 Oct 2024 | Pengumuman | Dexcom Reports Third Quarter 2024 Financial Results |
| 04 Oct 2024 | Pengumuman | Expanding Continuous Glucose Monitoring Options: How Glucotrack Is Helping Usher In The Next Generation Of Diabetes Care Technology |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |